23 results
8-K
EX-99.1
3kdl6fvl 0goz8m2mr
4 Nov 21
Vaxart Provides Business Update and Reports Third Quarter 2021 Financial Results
4:06pm
8-K
EX-99.1
fzgb5vxujx9 0pzogrf
23 Aug 21
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
4:23pm
8-K
jwcwh
23 Aug 21
Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors
4:23pm
8-K
EX-99.1
3mpoqj24fiwpvqeg
5 Aug 21
Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results
4:08pm
8-K/A
EX-99.1
d682au
23 Jan 13
Consolidated Statements of Operations
12:00am
DEFA14A
5kf9mz l0
23 Aug 12
Additional proxy soliciting materials
12:00am
DEFM14A
d6hcg52 hi
7 Aug 12
Proxy related to merger
12:00am
DEFA14A
6vlymx
24 Apr 12
Additional proxy soliciting materials
12:00am